These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 14428956)

  • 1. The action of methylic antigen and directions for its use in the treatment of tuberculosis.
    OPRESCU CC
    Rum Med Rev; 1959; 3():65-6. PubMed ID: 14428956
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chemical and biological properties of phosphatide fractions isolated from "the methylic antigen" of Mycobacterium tuberculosis].
    Pigretti M; Vilkas E; Lederer E; Bloch H
    Bull Soc Chim Biol (Paris); 1965; 47(11):2039-46. PubMed ID: 4956688
    [No Abstract]   [Full Text] [Related]  

  • 3. Understanding the biology of 16 kDa antigen of Mycobacterium tuberculosis: scope in diagnosis, vaccine design and therapy.
    Siddiqui KF; Amir M; Agrewala JN
    Crit Rev Microbiol; 2011 Nov; 37(4):349-57. PubMed ID: 21919701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiseptic Action of Glycerite of Hydrogen Peroxide on Mycobacterium tuberculosis (var. hominis).
    Brown EA; Slanetz LW
    Science; 1947 Mar; 105(2725):312-3. PubMed ID: 17740558
    [No Abstract]   [Full Text] [Related]  

  • 5. [The serodiagnostic value of antigens secreted from Mycobacterium tuberculosis].
    Wang EL; Liu WT; Li T
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jul; 29(7):466-9. PubMed ID: 17045047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of genetically engineered iNKT cells expressing TCRs specific for the M. tuberculosis 38-kDa antigen.
    Jiang ZM; Luo W; Wen Q; Liu SD; Hao PP; Zhou CY; Zhou MQ; Ma L
    J Transl Med; 2015 May; 13():141. PubMed ID: 25943357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Objective evaluation of antituberculotic agents in mice, infected with the Ravenel strain of Mycobacterium tuberculosis var. bovis].
    KOCZKA I
    Kiserl Orvostud; 1955 Sep; 7(5):487-96. PubMed ID: 13286857
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemoresistance of Mycobacterium tuberculosis; general aspects and relation to clinical manifestations and therapy; immunity and allergy in antibacterial-treated tuberculosis].
    NITTI V; CURCI G
    G Ital Chemioter; 1954; 1(3-4):390-421. PubMed ID: 14391652
    [No Abstract]   [Full Text] [Related]  

  • 9. [Resistance of Mycobacterium tuberculosis to streptomycin].
    BEEUWKES H; VOS H
    Poumon; 1952 Jan; 8(1):25-39. PubMed ID: 14911483
    [No Abstract]   [Full Text] [Related]  

  • 10. Secondary metabolites from Chamaedora tepejilote (Palmae) are active against Mycobacterium tuberculosis.
    Jiménez A; Meckes M; Alvarez V; Torres J; Parra R
    Phytother Res; 2005 Apr; 19(4):320-2. PubMed ID: 16041726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of the host in the development of streptomycin resistance in Mycobacterium tuberculosis].
    LENTSNER AA
    Probl Tuberk; 1954; 4():55-9. PubMed ID: 13215496
    [No Abstract]   [Full Text] [Related]  

  • 12. Activity of helvolic acid against Mycobacterium tuberculosis.
    JENNINGS MA
    Nature; 1945; 156():633. PubMed ID: 21006490
    [No Abstract]   [Full Text] [Related]  

  • 13. [Combined streptomycin and methylic antigen therapy of tuberculinized guinea-pigs by a resistant strain].
    TISON F
    Ann Inst Pasteur (Paris); 1951 Feb; 80(2):210-12. PubMed ID: 14829900
    [No Abstract]   [Full Text] [Related]  

  • 14. [Development of resistance of Mycobacterium tuberculosis to phthivazide during therapy].
    MAKEEVA OO
    Probl Tuberk; 1954; 4():35-9. PubMed ID: 13215492
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of repeated simultaneous studies on the resistance of Mycobacterium tuberculosis to streptomycin and isoniazid].
    ZEBROWSKI T; BOROWIECKA A; PIENIAZEK J
    Pol Tyg Lek (Wars); 1957 Aug; 12(33):1269-73. PubMed ID: 13484559
    [No Abstract]   [Full Text] [Related]  

  • 16. [Analysis and application of polypeptide antigens of 13 mycobacterium strains].
    Lu X; Zhang Y; Zhang X
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Mar; 21(3):170-3. PubMed ID: 11263356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of respiratory allergy with tuberculous antigen; Mycobacterium tuberculosis as pathogenic agent; personal experiences].
    PRIBLUDA P
    Sem Med; 1951 Sep; 99(10):440-7. PubMed ID: 14876484
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis.
    Coppola M; van den Eeden SJ; Wilson L; Franken KL; Ottenhoff TH; Geluk A
    Clin Vaccine Immunol; 2015 Sep; 22(9):1060-9. PubMed ID: 26202436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sensitivity of Mycobacterium tuberculosis to isonicotinic acid hydrazide and bactericidal effect of Wrocław shock method].
    BEKIERKUNST A; SZNURA J
    Arch Immunol Ther Exp (Warsz); 1954; 2():37-47. PubMed ID: 13269293
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the antigens and "crude extracts" of Mycobacterium tuberculosis].
    TOGUNOVA AI; ZHULINA LV; KHATENEVER ML
    Probl Tuberk; 1962; 40(4)():71-6. PubMed ID: 13921558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.